Journal article
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis
Abstract
BACKGROUND: A total of 2.8 million people are living with multiple sclerosis and due to disparities in access to medicines, the ability to treat this condition varies widely. Off-label disease-modifying therapies are sometimes more available or affordable in different health systems. Appropriate methodology is integral in creating high-quality and trustworthy guidelines. In this article, we outline Multiple Sclerosis International Federation's …
Authors
Piggott T; Nonino F; Baldin E; Filippini G; Rijke N; Schünemann H; Laurson-Doube J
Journal
Multiple Sclerosis Journal - Experimental Translational and Clinical, Vol. 7, No. 4,
Publisher
SAGE Publications
Publication Date
October 2021
DOI
10.1177/20552173211051855
ISSN
2055-2173